The 20 Best Cystectomy Doctors Near Me

Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network. Dr. Lerner is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Lerner is currently accepting new patients.

Dr. Max Kates is the R. Christian B. Evensen Professor and an associate professor of urology and oncology at the Brady Urological Institute at Johns Hopkins. He also directs the Division of Urologic Oncology for the Brady Urological Institute. Dr. Kates completed his undergraduate degree at Wesleyan University in Connecticut before pursuing his medical degree at Mount Sinai School of Medicine in New York. He then went on to train at Johns Hopkins for his urologic residency and Society of Urologic Oncology (SUO) fellowship. Dr. Kates has expertise in all areas of urologic oncology, with a particular emphasis on bladder and prostate cancer. With training in open, endoscopic, and robotic surgical approaches, Dr. Kates’ surgical philosophy is to assess the unique needs of each patient, and develop the right treatment plan for their malignancy. He is very hands on in his approach in the clinic and the operating room, and believes open communication with the patient, the patient’s family, and referring providers is key to ensuring a speedy recovery. As the clinical director of the bladder cancer multidisciplinary clinic, Dr. Kates works with the team at the Johns Hopkins Greenberg Bladder Cancer Institute to deliver a personalized approach to bladder cancer utilizing cutting edge precision medicine approaches. Dr. Kates’ research interests involve novel treatments for cancers of the urinary tract. Dr. Kates has authored more than 135 journal articles in the fields of bladder, prostate, and kidney cancer. He currently has a provisional patent for a novel intravesical chemotherapy developed with nano-engineer collaborators. Additionally, Dr. Kates has made important discoveries into the mechanism of action of intravesical BCG, the most common treatment for bladder cancer. He is the principal investigator on multiple trials, and is currently leading EA8212 BRIDGE, which is a randomized trial open in over 150 centers in the United States comparing BCG to GemDoce chemotherapy for early stage bladder cancer. To inquire about an appointment or make a referral, Dr. Kates can be contacted by phone (410) 614-0009. Dr. Kates is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Kates is board certified in American Board Of Urology.

Jihad Kaouk is a Urologist practicing medicine in Cleveland, Ohio. He has been practicing medicine for over 37 years. Dr. Kaouk is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Horseshoe Kidney, Nephrectomy, and Prostatectomy. Dr. Kaouk is board certified in American Board Of Urology, 2013.

Peter Clark is a Urologist practicing medicine in Charlotte, North Carolina. Dr. Clark is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Nephrectomy. Dr. Clark is board certified in American Board Of Urology. Dr. Clark is currently accepting new patients.

Dr. Mark A. Preston is a urologic surgeon at Brigham and Women’s Hospital and Associate Professor of Surgery at Harvard Medical School. Dr. Preston received his Medical Degree from the University of Ottawa in Canada, where he also completed his residency training in Urology. He completed a three-year accredited fellowship in Urologic Oncology at Massachusetts General Hospital including a Masters of Public Health from the Harvard School of Public Health with a concentration in clinical effectiveness. He is board certified in Urology.Dr. Preston’s clinical interests include urologic oncology (bladder, kidney, prostate and testicular cancer) and minimally invasive surgery. Dr. Preston’s research focuses on the epidemiology of prostate and kidney cancer risk with an emphasis on predictive biomarkers and pharmacoepidemiology. Dr. Preston is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Preston is board certified in Urology.

Dr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer. Dr. Mossanen is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Penile Cancer, Cystectomy, and Nephrectomy. Dr. Mossanen is board certified in Urology.

Thomas Guzzo is a Urologist practicing medicine in Philadelphia, Pennsylvania. Dr. Guzzo is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy. Dr. Guzzo is board certified in Urology, 2011. Dr. Guzzo is currently accepting new patients.

Francesco Montorsi practices practicing medicine in Milan, Italy. Mr. Montorsi is rated as an Elite expert by MediFind in Cystectomy. He is also highly rated in 56 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Cystectomy.

Alberto Briganti practices practicing medicine in Milan, Italy. Mr. Briganti is rated as an Elite expert by MediFind in Cystectomy. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Cystectomy.

George Thalmann practices practicing medicine in Bern, Switzerland. Mr. Thalmann is rated as an Elite expert by MediFind in Cystectomy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy.

Andrea Gallina practices practicing medicine in Milan, Italy. Ms. Gallina is rated as an Elite expert by MediFind in Cystectomy. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Prostate Cancer, Urothelial Cancer, Prostatectomy, and Cystectomy.

Morgan Roupret practices practicing medicine in Paris, France. Mr. Roupret is rated as an Elite expert by MediFind in Cystectomy. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Bladder Cancer, Nephrectomy, and Cystectomy.

Arnulf Stenzl practices practicing medicine in Tuebingen, Germany. Mr. Stenzl is rated as an Elite expert by MediFind in Cystectomy. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Cystectomy, and Lymphadenectomy.

Eric Wallen is Professor and Chair of the Urology Department at MUSC. His clinical work is focused on patient-centered delivery of care to patients with urologic malignancies such as prostate, kidney, bladder, and testicular cancer. He is an expert in robotic surgery with over 20 years of experience. Prior to assuming the chair position at MUSC he was Professor, Vice-Chair of Education, Program Director, and Medical Director of System Supply Chain at UNC Chapel Hill. He graduated from Yale College with a degree in political science and received his MD from the University of California, Los Angeles. His urologic training was completed at Stanford University. Dr. Wallen is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Prostate Cancer, Cystectomy, and Nephrectomy.

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

Fiona Burkhard practices practicing medicine in Bern, Switzerland. Ms. Burkhard is rated as an Elite expert by MediFind in Cystectomy. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Bladder Outlet Obstruction, Bladder Cancer, Urinary Incontinence, Cystectomy, and Lymphadenectomy.

Dr. Jeffery Montgomery's clinical interests include the diagnosis and management of bladder, prostate, and penile and testicular cancers. With his advanced training in urologic oncology and minimally invasive surgical techniques, such as robotic, laparoscopic and complex open surgery, he is able to deliver state-of-the-art care to his patients. He has expertise in state-of-the-art diagnostics for prostate cancer, including prostate MRI, fusion prostate biopsy, and transperineal standard and fusion prostate biopsies. He has extensive experience performing advanced robotic surgery, including prostatectomy, cystectomy with intra-corporeal urinary diversions, and inguinal lymph node dissections. Dr. Montgomery's research focuses on improving the quality and efficiency of urologic oncology disease management. Dr. Montgomery is a Michigan native and earned his undergraduate degree from the University of Michigan. He then went on to complete his medical education at the Columbia University College of Physicians and Surgeons in New York before finishing his Urology residency at the University of Michigan. He completed his urologic oncology fellowship at the University of Texas MD Anderson Cancer Center. Dr. Montgomery is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Montgomery is board certified in Urology.

An approach to health and well being that includes not only most advanced treatments, but also considers patient beliefs and quality of life. Dr. Miocinovic is rated as an Advanced provider by MediFind in Cystectomy. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Ureteral Reconstruction, and Nephrectomy. Dr. Miocinovic is board certified in Urology and Robotic Surgery.

Siamak Daneshmand is a Urologist practicing medicine in Los Angeles, California. Dr. Daneshmand is rated as an Elite provider by MediFind in Cystectomy. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Testicular Cancer, Cystectomy, and Bladder Reconstruction.

Marco Moschini practices practicing medicine in Barcelona, Spain. Mr. Moschini is rated as an Elite expert by MediFind in Cystectomy. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Prostatectomy.